• Summit Therapeutics Inc. (NASDAQ:SMMT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

    Источник: Buzz FX / 05 янв 2025 06:51:13   America/New_York


    Summit Therapeutics Inc. (NASDAQ:SMMT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 5, 2025 Share Link copied to clipboard. Summit Therapeutics Inc.
    Read more...
Опубликовать